Physician profile
Jose Ortiz
NPI 1013124544
$1,313.36
in general payments reported to CMS, 2019-2025
18 companies · $62.40 in 2025
The $62.40 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $90.96 · 2021: $75.40 · 2022: $178 · 2023: $465 · 2024: $299 · 2025: $62.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $826.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $826.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $209.91 | 2023-2024 | |
| Amgen INC. | $140.54 | 2022-2024 | Repatha |
| Amarin Pharma, INC. | $140.27 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $136.87 | 2022-2024 | Breztri, Airsupra |
| Boston Scientific Corporation | $126.81 | 2023 | Watchman Access System |
| Ironwood Pharmaceuticals, INC | $125.00 | 2024 | |
| Mannkind Corporation | $84.09 | 2023 | V-Go |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $66.43 | 2021-2022 | |
| Astellas Pharma US INC | $59.18 | 2023-2025 | Veozah |
| Exact Sciences Corporation | $45.81 | 2025 | Cologuard Collection Kit |
| Pfizer INC. | $43.10 | 2020 | |
| Glaxosmithkline, LLC. | $24.29 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $22.47 | 2024 | Kristalose |
| Global Blood Therapeutics, INC. | $21.11 | 2021 | |
| Smith+Nephew, INC. | $19.62 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $16.92 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.65 | 2020 | |
| Lilly USA, LLC | $14.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Ortiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.